Skip to content
ESPT
MARKETS / BALCAO / Industrials / Engineering and consulting / PBSV
BALCAO · SERVICES-MANAGEMENT CONSULTING SERVICES · SMALL CAP

Pharma-Bio Serv, Inc. PBSV

16 fiscal years on record · USD · FY2025 reported · SEC filings only
$9.0M
▼ 5.3% YoY
$-100,463
$-221,530

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

The Company operates in Puerto Rico, the United States, Europe and Brazil under the name of Pharma-Bio Serv, and is engaged in providing technical compliance consulting services to the pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies. We are a regulatory affairs, quality, compliance and technology transfer services consulting firm with headquarters in Puerto Rico, servicing the Puerto Rico, United States and European markets, and to a lesser extent the Brazilian market. We provide a broad range of compliance-related consulting services. We market our services to pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies principally in Puerto Rico, the United States, Europe and Brazil. We seek opportunities in markets that can yield profitable margins using our professional consulting force.

Written from the business description in Pharma-Bio Serv, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 29 January 2026. Every sentence was checked against that document before publication.

Growth

USD 9.0M
Revenue, FY2025 · full 16-year series below
Revenue $M Net income $M
FY2025 · Revenue 9.0 · Net income -0.1
15M30M
201020132016201920222025
Compound annual growth
−22.6%
−16.0%
−9.1%
−1.5%
−20.8%
+0.3%
+26.4%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at −16.0% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−1 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -7.1% · Net -1.1%
5%10%15%-5%-10%-15%
201020172025
ROE
FY2025 · ROE -0.8%
20%40%-5%-10%
201020172025
Three returns, three denominators.
Gross margin32.3%
Operating margin-7.1%
Net margin-1.1%
EBITDA·

Each USD of equity lost 1 cents this year.

Cash & shareholders

USD 1.8M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -0.2
2M4M-1M-2M
201020172025
Net buybacks $M Dividends $M
FY2025 · Dividends 1.7 · Net buybacks 0.0
2M3M
2014201620182020202220242025
Dividends paidUSD 1.7M
Net buybacksUSD 31,443.00
Share of profit-1743.3%
Consecutive raises·

USD 1.7M in dividends and USD 31,443.00 in buybacks went back to shareholders in a year without profit.

Total assetsUSD 13.7M
EquityUSD 11.9M
CashUSD 3.4M
Current ratio7.70×

Equity funds 87% of total assets.

The 16-year record

16 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative—not applicable◌not available in our data
PBSV, 16-year financial record
Metric 2025202420232022202120202019201820172016201520142013201220112010
Revenue $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Operating income $B−0.0−0.00.00.0−0.00.00.0−0.0−0.0−0.00.00.00.00.00.00.0
EBITDA $B◌◌◌0.0−0.00.00.0−0.0−0.00.00.00.00.00.00.00.0
Income tax $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Net income $B−0.0−0.00.00.0−0.00.00.00.0−0.0−0.00.00.00.00.00.00.0
Free cash flow $B−0.0−0.00.00.00.00.0−0.00.0−0.0−0.00.00.00.00.00.00.0
EPS, diluted $−0.00−0.030.06◌◌0.090.09◌−0.06−0.010.070.100.210.200.140.02
Dividend / sh $◌◌◌◌◌◌0.07◌◌◌◌◌◌◌◌◌
Payout %−1712−221132342−83840—————————
ROE %−0.8−5.28.05.7−10.09.510.26.2−6.6−1.27.712.531.744.447.57.3
Shares out B0.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.02

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

AAPL · F · GM · DELL · TSLA · FDX
Provenance

Company facts, as filed

How we verify · 0 failures in 77 reconciliationsAUDITED

Reconciled in 16 of the 16 fiscal years we could check. Six checks were skipped: the balance sheet is not tagged before 2010. Three checks were skipped: EPS is not tagged before 2010. Three checks were skipped: revenue is not tagged before 2010.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityServices-Management Consulting Services
Listed onOTC market
Incorporated innot stated in the filings
Fiscal year endsOctober 31
SEC categorysmaller reporting company
Data on record since2010

Share this section

Download image